About us

ITINERARE integrates three major axes on gene therapy, molecular therapies, and ethics, legal and social innovations (ELSI). Currently our consortium includes 36 members from 5 UZH faculties, the University Hospital Zurich (USZ) and the University Children’s Hospital Zurich (KISPI). We engage in multi-disciplinary collaboration and training on all aspects associated with basic research into rare diseases and the translation of cutting-edge therapies into clinical practice.